Fig. 4.
E2 increased BMP2 and HOXC6 expression in DMSCs through the recruitment of KDM6B to promoters and removal of H3K27me3 marks. Occupancy of KDM6B at the BMP2 (a) and HOXC6 (b) promoters, as determined by ChIP, upon E2 treatment. Occupancy of H3K27me3 at the BMP2 (c) and HOXC6 (d) promoters, as determined by ChIP, upon E2 treatment. Occupancy of KDM6B at the BMP2 (e) and HOXC6 (f) promoters in the control and KDM6B-depleted DMSCs, as determined by ChIP, upon E2 treatment. Occupancy of H3K27me3 at the BMP2 (g) and HOXC6 (h) promoters in the control and KDM6B-depleted DMSCs, as determined by ChIP, upon E2 treatment. Data are presented as the mean ± SEM (n = 3). All the groups were compared by two-way ANOVA with Bonferroni post hoc test. Asterisks were assigned to P values with statistical significance (*P < 0.05; **P < 0.01; ***P < 0.001)